BRASILIA (dpa-AFX) - Tokai Pharmaceuticals, Inc. has priced its initial public offering of 6.48 million shares of common stock at $15.00 per share.
Tokai has granted the underwriters a 30-day option to buy up to an additional 972,000 shares at the public offering price, less underwriting discounts and commissions.
Post offering, the company's common stock is expected to trade on the Nasdaq from Wednesday, September 17, under ticker 'TKAI'.
BMO Capital Markets, Stifel and William Blair are acting as joint book-running managers for the offering , while Janney Montgomery Scott is acting as co-manager.
Copyright RTT News/dpa-AFX